Smartleaf Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Hold
2,100
0.01% 884
2026
Q1
$175K Sell
2,100
-54
-3% -$4.85K 0.01% 836
2025
Q4
$189K Sell
2,154
-604
-22% -$45.8K 0.01% 824
2025
Q3
$156K Sell
2,758
-96
-3% -$5.53K 0.01% 840
2025
Q2
$167K Sell
2,854
-306
-10% -$19.8K 0.01% 638
2025
Q1
$229K Sell
3,160
-850
-21% -$70.2K 0.02% 528
2024
Q4
$332K Buy
4,010
+351
+10% +$27.7K 0.03% 417
2024
Q3
$258K Buy
3,659
+657
+22% +$46.4K 0.03% 431
2024
Q2
$207K Buy
3,002
+600
+25% +$35.8K 0.03% 373
2024
Q1
$127K Buy
2,402
+32
+1% +$1.72K 0.02% 467
2023
Q4
$128K Buy
+2,370
New +$116K 0.03% 386

Other funds holding GMED

Smartleaf Asset Management's GMED Position: Q2 2026 in Review

Smartleaf Asset Management held its Globus Medical (GMED) position steady in Q2 2026 at 2,100 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #884.

Smartleaf Asset Management first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $332K in Q4 2024. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Smartleaf Asset Management held 2,100 shares of Globus Medical worth $176K as of Q2 2026.
  • Smartleaf Asset Management left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #884 holding.
  • Smartleaf Asset Management first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Globus Medical position peaked at $332K in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.